Mehanna Carl-Joe, Abdul Fattah Maamoun, Tamim Hani, Nasrallah Mona P, Zreik Raya, Haddad Sandra S, El-Annan Jaafar, Raad Samih, Haddad Randa S, Salti Haytham I S
Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
Biostatistics Unit, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
J Ophthalmol. 2017 May 31;2017:9805145. doi: 10.1155/2017/9805145. eCollection 2017.
To estimate the 5-year incidence of progression rate and regression rate and risk factors for diabetic retinopathy (DR) in a cohort of Lebanese patients with type II diabetes.
We followed a cohort of 462 Lebanese patients with type II diabetes for over 5 years at the American University of Beirut Medical Center. Patients underwent yearly complete ophthalmic evaluation and fundus photographs and were assessed for the incidence, stage, and evolution of DR using modified Airlie House classification.
Among the 462 patients, 281 had no DR at baseline. The 5-year cumulative incidence of any DR was 10% (95% CI: 6-13), and only baseline microalbuminuria correlated with the development of DR (OR = 10.53, 95% CI: 4.39-25.23, < 0.0001). Among the 181 patients with baseline DR, the worsening and regression rates of DR were 31.5% (95% CI: 25-38) and 9% (95% CI: 5-13), respectively. Microalbuminuria also approached statistical significance as a risk factor for DR worsening (OR = 1.89, 95% CI: 0.97-3.70, = 0.06).
The 5-year incidence of DR in this hospital-based cohort is relatively low. Microalbuminuria was independently associated with the incidence and progression of the disease. We recommend to screen patients with type II diabetes for microalbuminuria as prognostic for the development and worsening of DR.
评估黎巴嫩II型糖尿病患者队列中糖尿病视网膜病变(DR)的5年进展率、回归率及危险因素。
我们在贝鲁特美国大学医学中心对462例黎巴嫩II型糖尿病患者进行了5年多的随访。患者每年接受一次全面的眼科评估和眼底照相,并使用改良的阿利屋分类法评估DR的发生率、分期和进展情况。
在462例患者中,281例基线时无DR。任何DR的5年累积发生率为10%(95%CI:6-13),只有基线微量白蛋白尿与DR的发生相关(OR=10.53,95%CI:4.39-25.23,<0.0001)。在181例基线时有DR的患者中,DR的恶化率和回归率分别为31.5%(95%CI:25-38)和9%(95%CI:5-13)。微量白蛋白尿作为DR恶化的危险因素也接近统计学意义(OR=1.89,95%CI:0.97-3.70,=0.06)。
在这个以医院为基础的队列中,DR的5年发生率相对较低。微量白蛋白尿与疾病的发生和进展独立相关。我们建议对II型糖尿病患者进行微量白蛋白尿筛查,以预测DR的发生和恶化。